TAK · Takeda Pharmaceutical Co Ltd
$17.63
+0.24 (+1.38%)
At close · Aug 14
Market Cap
$56.30B
Shares
3.19B
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-08-14 | Nicola Greenway | Chief Human Resources Officer | 12,980 | 2026-08-14 | Interactive Brokers LLC |
| 2026-08-10 | Elaine Shannon | President, Global Supply & Quality | 20,363 | 2026-08-11 | Interactive Brokers LLC |
| 2026-08-06 | Nicola Greenway | Chief Human Resources Officer | 34,603 | 2026-08-07 | Interactive Brokers LLC |
| 2025-12-09 | Lauren Rusckowski Duprey | Chief Human Resources Officer | 29,619 | 2025-12-09 | Interactive Brokers LLC |
| 2025-12-05 | Teresa Marie Bitetti | President, Global Oncology Business Unit | 87,023 | 2025-12-05 | Interactive Brokers LLC |
| 2025-12-04 | Giles Richard Platford | President, Plasma-Derived Therapies Business Unit | 58,421 | 2025-12-04 | Interactive Brokers LLC |
| 2025-07-09 | Marcello Pignagnoli Agosti | Global Business Development Officer | 18,622 | 2025-07-09 | Interactive Brokers LLC |
| 2025-07-09 | Lauren Rusckowski Duprey | Chief Human Resources Officer | 40,919 | 2025-07-09 | Interactive Brokers LLC |
| 2025-07-09 | Gabriele Ricci | Chief Data & Technology Officer | 26,874 | 2025-07-09 | Interactive Brokers LLC |
| 2025-07-09 | Christophe Pierre Weber | Chief Executive Officer | 34,857 | 2025-07-09 | Interactive Brokers LLC |
| 2025-07-09 | Andrew Plump | President, Research & Development | 169,313 | 2025-07-09 | Interactive Brokers LLC |
| 2025-07-09 | Akiko Amakawa | Corporate Strategy Officer & CEO Chief of Staff | 5,608 | 2025-07-09 | Interactive Brokers LLC |
| 2025-07-09 | Thomas Wozniewski | Global Manufacturing & Supply Officer | 6,136 | 2025-07-09 | Interactive Brokers LLC |
| 2025-07-09 | Giles Richard Platford | President, Plasma-Derived Therapies Business Unit | 28,552 | 2025-07-09 | Interactive Brokers LLC |
| 2025-07-09 | Teresa Marie Bitetti | President, Global Oncology Business Unit | 52,649 | 2025-07-09 | Interactive Brokers LLC |
| 2025-07-09 | Elaine Mary Shannon | Global Quality Officer | 4,477 | 2025-07-09 | Interactive Brokers LLC |
| 2025-07-09 | Julie Kim | President, US Business Unit | 58,559 | 2025-07-09 | Interactive Brokers LLC |
| 2025-07-09 | Ramona A Sequeira | President, Global Portfolio Division | 102,972 | 2025-07-09 | Interactive Brokers LLC |
| 2024-08-22 | Giles Richard Platford | President, Plasma-Derived Therapies Business Unit | 19,073 | 2024-08-23 | Interactive Brokers LLC |
| 2024-07-10 | Ramona A Sequeira | President, Global Portfolio Division | 74,654 | 2024-07-11 | Interactive Brokers LLC |
| 2024-07-10 | Giles Richard Platford | President, Plasma-Derived Therapies Business Unit | 20,721 | 2024-07-11 | Interactive Brokers LLC |
| 2024-07-10 | Elaine Mary Shannon | Global Quality Officer | 4,612 | 2024-07-11 | Interactive Brokers LLC |
| 2024-07-10 | Christophe Pierre Weber | Chief Executive Officer | 14,890 | 2024-07-11 | Interactive Brokers LLC |
| 2024-07-10 | Akiko Amakawa | Corporate Strategy Officer & CEO Chief of Staff | 6,048 | 2024-07-11 | Interactive Brokers LLC |
| 2024-07-10 | Lauren Rusckowski Duprey | Chief Human Resources Officer | 27,603 | 2024-07-11 | Interactive Brokers LLC |
| 2024-07-10 | Thomas Wozniewski | Global Manufacturing & Supply Officer | 4,533 | 2024-07-11 | Interactive Brokers LLC |
| 2024-07-10 | Marcello Pignagnoli Agosti | Global Business Development Officer | 10,674 | 2024-07-11 | Interactive Brokers LLC |
| 2024-07-10 | Julie Kim | President, US Business Unit | 37,219 | 2024-07-11 | Interactive Brokers LLC |
| 2024-07-10 | Teresa Marie Bitetti | President, Global Oncology Business Unit | 38,479 | 2024-07-11 | Interactive Brokers LLC |
| 2024-07-10 | Gabriele Ricci | Chief Data & Technology Officer | 6,132 | 2024-07-11 | Interactive Brokers LLC |
| 2024-07-10 | Andrew Plump | President, Research & Development | 121,125 | 2024-07-11 | Interactive Brokers LLC |
| 2023-07-10 | Lauren Duprey | Chief Human Resources Officer | 10,732 | 2023-07-11 | Interactive Brokers LLC |
| 2023-07-10 | Giles Richard Platford | President, Plasma-Derived Therapies Business Unit | 24,394 | 2023-07-11 | Interactive Brokers LLC |
| 2023-07-10 | Gerard M Greco | Global Quality Officer | 31,065 | 2023-07-11 | Interactive Brokers LLC |
| 2023-07-10 | Marcello Pignagnoli Agosti | Global Business Development Officer | 10,522 | 2023-07-11 | Interactive Brokers LLC |
| 2023-07-10 | Mwana Lugogo | Chief Ethics & Compliance Officer | 2,045 | 2023-07-11 | Interactive Brokers LLC |
| 2023-07-10 | Ramona A Sequeira | President, Global Portfolio Division | 68,184 | 2023-07-11 | Interactive Brokers LLC |
| 2023-07-10 | Thomas Wozniewski | Global Manufacturing & Supply Officer | 4,789 | 2023-07-11 | Interactive Brokers LLC |
| 2023-07-10 | Julie Kim | President, US Business Unit | 29,403 | 2023-07-11 | Interactive Brokers LLC |
| 2023-07-10 | Gabriele Ricci | Chief Data & Technology Officer | 9,436 | 2023-07-11 | Interactive Brokers LLC |
| 2023-07-10 | Andrew Plump | President, Research & Development | 138,264 | 2023-07-11 | Interactive Brokers LLC |
| 2023-07-10 | Teresa Marie Bitetti | President, Global Oncology Business Unit | 46,424 | 2023-07-11 | Interactive Brokers LLC |
Showing 1–42 of 42 filings